SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 184 filers reported holding SANGAMO THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.39 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $22 | -71.8% | 17,264 | -30.6% | 0.00% | -80.0% |
| Q4 2022 | $78 | -99.9% | 24,880 | +63.9% | 0.01% | -16.7% |
| Q4 2021 | $114,000 | -46.0% | 15,176 | +12.1% | 0.01% | -47.8% |
| Q4 2020 | $211,000 | +5.0% | 13,543 | -36.2% | 0.02% | -32.4% |
| Q3 2020 | $201,000 | -54.6% | 21,232 | -57.0% | 0.03% | -33.3% |
| Q2 2020 | $443,000 | +321.9% | 49,426 | +293.9% | 0.05% | +410.0% |
| Q4 2019 | $105,000 | -79.6% | 12,548 | -77.9% | 0.01% | -75.0% |
| Q3 2019 | $514,000 | +111.5% | 56,760 | +123.2% | 0.04% | +185.7% |
| Q1 2019 | $243,000 | +88.4% | 25,430 | +126.7% | 0.01% | +100.0% |
| Q4 2018 | $129,000 | -45.6% | 11,215 | -32.7% | 0.01% | -30.0% |
| Q2 2018 | $237,000 | -67.4% | 16,662 | -56.5% | 0.01% | -74.4% |
| Q1 2018 | $727,000 | – | 38,284 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WASATCH ADVISORS LP | 17,986,781 | $10,788,471 | 0.07% |
| PUBLIC EMPLOYEES RETIREMENT ASSOCIATION OF COLORADO | 254,257 | $12,790 | 0.03% |
| Long Focus Capital Management, LLC | 1,372,000 | $822,926 | 0.03% |
| GSA CAPITAL PARTNERS LLP | 559,731 | $336 | 0.03% |
| Rokos Capital Management LLP | 6,474,348 | $3,940,936 | 0.03% |
| Golden State Equity Partners | 166,265 | $99,726 | 0.03% |
| State of Wyoming | 92,360 | $55,398 | 0.01% |
| ExodusPoint Capital Management, LP | 1,890,425 | $1,134 | 0.01% |
| ACADIAN ASSET MANAGEMENT LLC | 2,927,769 | $1,753 | 0.01% |
| Fort Sheridan Advisors LLC | 53,831 | $32,288 | 0.01% |